Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.

Related Articles


Cardiogenic Shock: Protocols, Teams, Centers, and Networks

Alex F Warren, Carolyn Rosner, Raghav Gattani,


Citation: US Cardiology Review 2021;15:e18.

Cardiac Transplant and Ventricular Assist in Heart Failure

Michael T Cain, Michael S Firstenberg, Joseph C Cleveland Jr,


Citation: US Cardiology Review 2021;15:e16.

Describing and Classifying Shock: Recent Insights

Ashleigh Long, Amin Yehya, Kelly Stelling,


Citation: US Cardiology Review 2021;15:e15.

Optimizing GDMT for HFrEF During Hospitalization

Neal M Dixit, Shivani Shah, Boback Ziaeian,


Citation: US Cardiology Review 2021;15:e07.